Home
Team
Portfolio
Blog
Contact
Investors
More
Our Recent Posts
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
RevLocal Acquired by Hibu, an H.I.G. Capital Portfolio Company
Archive
Authenticx Accelerates AI Innovation in First Half of 2024
eBlu Solutions Appoints Doug Lawrence as Chief Revenue Officer
OrthAlign CEO Eric Timko named a Top 25 Medical Device Executive of 2024